Cite
Lobo B, Ramos L, Martínez C, et al. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. United European Gastroenterol J. 2017;5(6):887-897doi: 10.1177/2050640617691690.
Lobo, B., Ramos, L., Martínez, C., Guilarte, M., González-Castro, A. M., Alonso-Cotoner, C., Pigrau, M., de Torres, I., Rodiño-Janeiro, B. K., Salvo-Romero, E., Fortea, M., Pardo-Camacho, C., Guagnozzi, D., Azpiroz, F., Santos, J., & Vicario, M. (2017). Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. United European gastroenterology journal, 5(6), 887-897. https://doi.org/10.1177/2050640617691690
Lobo, Beatriz, et al. "Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study." United European gastroenterology journal vol. 5,6 (2017): 887-897. doi: https://doi.org/10.1177/2050640617691690
Lobo B, Ramos L, Martínez C, Guilarte M, González-Castro AM, Alonso-Cotoner C, Pigrau M, de Torres I, Rodiño-Janeiro BK, Salvo-Romero E, Fortea M, Pardo-Camacho C, Guagnozzi D, Azpiroz F, Santos J, Vicario M. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. United European Gastroenterol J. 2017 Oct;5(6):887-897. doi: 10.1177/2050640617691690. Epub 2017 Jan 29. PMID: 29026603; PMCID: PMC5625876.
Copy
Download .nbib